Impact of New Chemotherapeutic and Targeted Agents on Survival in Stage IV Non-Small Cell Lung Cancer

PURPOSE. Significant advances in the systemic management of metastatic non-small cell lung cancer (NSCLC) have occurred over the past decade, with options now including multiple lines of chemotherapy, epidermal growth factor receptor inhibitors, and antiangiogenic agents. Improvements in overall sur...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Yu, Joanne L., Simmons, Christine, Victor, J. Charles, Han, Dolly, Hogeveen, Sophie, Leighl, Natasha, Verma, Sunil
Materialtyp: Artigo
Språk:Inglês
Publicerad: AlphaMed Press 2011
Ämnen:
Lung Cancer
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228167/
https://ncbi.nlm.nih.gov/pubmed/21835896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0079
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk